News & Events

Launch of Tolcylen™ Antifungal, Cosmetic and Nail Renewal Product

Marlinz Pharma is proud to announce the January 2017 launch of its Tolcylen™ Antifungal, Cosmetic and Nail Renewal product. Working with a team of experienced pharmacological scientists, the Tolcylen™ Antifungal/Nail Renewal Solution formulation was developed, tested and stabilized. Initially developed to be marketed as a prescription topical onychomycosis drug, Tolcylen™ was eventually perfected and introduced to the market as an OTC physician dispensed product. The highly specialized solution resulted in the filing of multiple patent applications covering the processes and formulations. The solution is delivered via a patented soft tube/applicator brush tip flow restrictor. The brush tip easily reaches the hyponychial and nail fold areas while the leak proof cap prevents waste and evaporation. Tolcylen™ Solution is the only product of any kind capable of rapidly improving the appearance of compromised nails with cosmetic agents, while also introducing an antifungal agent to the infected sites via a low molecular weight and low surface tension vehicle. Scientific and clinical data are available for licensed practitioners.

Marlinz Pharma announces the milestone of 50,000 units of Tolcylen™ products

Marlinz Pharma announces the milestone of 50,000 units of Tolcylen™ products dispensed as of August 21, 2017.  Since our full scale launch only 6 months ago over 500 accounts have made Tolcylen™ their standard office based treatment for onychomycosis and other nail pathologies.  Several comparative studies and clinical white papers are underway and early results are outstanding.  Marlinz Pharma has also completed the filing of our 5th patent application to cover the existing and new product combinations, formulations, surfactants and related proprietary processes making up the cornerstone of our one of a kind product portfolio.

Marlinz Pharma is proud to be a 2018 Podiatry Institute Gold Sponsor….

Meetings / Conferences

IPMA Annual Meeting
  • Schaumburg, IL
  • September 6-8
  • www.ipma.net
Top Practices Summit
Podiatry Institute Reconstructive Surgery of the Foot & Ankle
Podiatry Institute Insights & Advancements in Foot & Ankle Surgery
Colorado Foot & Ankle Society Conference
  • Greenwood Village, CO
  • September 28-29
  • www.colopma.org
Heartland Foot & Ankle Conference
  • Des Moines, IA
  • October  3-5
  • www.ipms.org
TPMA Southwest Foot & Ankle Conference
  • Frisco, TX
  • October 5-6
  • www.txpma.org
APMA GEF Kaplan-Clarke-Foster Seminar
  • Pinehurst, NC
  • October 10-14
  • www.apma.org/GEFAM
Podiatry Institute APMA Region 1
OKPMA Fall Symposium
Podiatry Institute Hallux Valgus & Related Forefoot Surgery
Goldfarb 2018 Clinical Conference
  • King of Prussia, PA
  • November 9-11
  • www.goldfarbfoundation.org
AENS Annual Conference
  • New Orleans, LA
  • November 9-11
  • www.aens.us
Podiatry Institute Windy City Conference
Kent State SE Conference
  • Orlando, FL
  • December 6 - 9
  • www.kent.edu
FPMA Science & Management Symposium
NYSPMA Clinical Conference
ACFAS Annual Scientific Conference
  • New Orleans, LA
  • February 14-16
  • www.acfas.org
Georgia Summit
AAD Annual Conference
  • Washington, DC
  • March 1-3
  • www.aad.org
Midwest Podiatry Conference
2019 DERMfoot

Invalid Input
Invalid Input
Invalid Input
Invalid Input